Big Gain For Cyclacel Pharmaceuticals, Inc.
Tue, Apr 30, 2024 at 07:23 PM
Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ) rocketted at $2.12, a gain of 55.9%. The stock appeared on our News Catalysts scanner on Tue, Apr 30, 2024 at 08:30 AM in the 'PRIVATE PLACEMENT' category. From Tue, Apr 16, 2024, the stock recorded 40.00% Up Days and 54.55% Green Days
About Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ)
Cyclacel Pharmaceuticals Inc is a biopharmaceutical company engaged in the discovery, development and commercialization of novel, mechanism-targeted drugs to treat cancer and other serious disorders, with development operations in US and UK.
Top 10 Gainers:
- Canopy Growth Corporation (CGC:NASDAQ), 78.85%
- Akili Inc. (AKLI:NASDAQ), 70.29%
- Global Mofy Metaverse Limited (GMM:NASDAQ), 59.09%
- Visionary Education Technology Holdings Group Inc. (GV:NASDAQ), 57.06%
- Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ), 55.88%
- GeneDx Holdings Corp Cl A (WGS:NASDAQ), 55.18%
- Arrowroot Acquisition Corp. (ARRW:NASDAQ), 54.64%
- IM Cannabis Corp. (IMCC:NASDAQ), 53.57%
- Leafly Holdings Inc. (LFLY:NASDAQ), 51.43%
- Aurora Cannabis Inc. (ACB:NASDAQ), 46.04%